What is the current size and annual growth rate of the osteoarthritis therapeutics market?
The osteoarthritis therapeutics market size has grown strongly in recent years. It will grow from $8.17 $ billion in 2024 to $8.87 $ billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to an aging population, advancements in drug delivery systems, increasing awareness and diagnosis, development of novel therapies, and rising obesity rates.
The osteoarthritis therapeutics market size is expected to see strong growth in the next few years. It will grow to $12.22 $ billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising obesity rates, advancements in treatment modalities, increasing awareness and diagnosis, development of disease-modifying osteoarthritis drugs (DMOADs), and government and private funding for research. Major trends in the forecast period include increasing focus on personalized medicine, the emergence of regenerative therapies, the expansion of pain management options, government and regulatory support, and rising demand in emerging markets.
Get Your Free Sample of The Global Osteoarthritis Therapeutics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19634&type=smp
Which major factors have contributed to the expansion of the osteoarthritis therapeutics market?
Rising sports injuries are expected to propel the growth of the osteoarthritis therapeutics market. A sports injury refers to any injury or harm that occurs during sports or athletic activities. These injuries can range in severity from small to severe, and they can affect various body parts. The increase in sports injuries is largely due to the rising participation in sports activities and the growing intensity and competitiveness of these activities. Osteoarthritis therapeutics are used in sports injuries to manage pain and inflammation and to improve joint function in athletes suffering from joint degeneration. For instance, in 2022, according to the National Safety Council, a US-based nonprofit, public service organization promoting health and safety, the incidence of sports and recreational injuries reported in 2022 rose by 12%. Therefore, rising sports injuries are driving the growth of the osteoarthritis therapeutics market.
How is the osteoarthritis therapeutics market segmented?
The osteoarthritis therapeuticsmarket covered in this report is segmented –
1) Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Other Drug Types
2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs
5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-uses
Subsegments:
1) Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products
2) Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors
3) Analgesics: Opioid Analgesics, Non-Opioid Analgesics, Topical Analgesics
4) Corticosteroids: Injectable Corticosteroids, Oral Corticosteroids, Intra-Articular Corticosteroids
5) Other Drug Types: Disease-Modifying Osteoarthritis Drugs (DMOADs), Platelet-Rich Plasma Therapy, Stem Cell Therapy
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/osteoarthritis-therapeutics-global-market-report
Who are the top competitors in the osteoarthritis therapeutics market?
Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Zimmer Biomet Holdings Inc., Horizon Therapeutics plc, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Galapagos NV, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Samumed LLC, Orthogen AG, Kolon Life Science Inc.
Which key trends are expected to influence the osteoarthritis therapeutics market in the coming years?
Major companies operating in the osteoarthritis therapeutics market are focused on developing innovative solutions, such as novel innovations for tissue regeneration in osteoarthritis. Tissue regeneration in osteoarthritis refers to the process of repairing or replacing damaged cartilage and joint tissues to restore normal function and alleviate pain. For instance, in May 2023, the Advanced Research Projects Agency for Health (ARPA-H), a US-based government agency, launched the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO). The Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program, initiated by the Advanced Research Projects Agency for Health (ARPA-H), focuses on developing cutting-edge injectable therapies that stimulate cartilage repair by leveraging biological pathways similar to those active during embryonic development. Unique features include a collaborative multimodal approach among research teams and advanced testing techniques such as “joint-on-a-chip” platforms to mimic joint environments, aiming to create regenerative solutions that address the underlying causes of osteoarthritis.
Which regional trends are influencing the osteoarthritis therapeutics market, and which area dominates the industry?
North America was the largest region in the osteoarthritis therapeutics market in 2022. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Osteoarthritis Therapeutics Market Report 2025 Offer?
The osteoarthritis therapeutics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Osteoarthritis therapeutics refer to the medical treatments and interventions used to manage and alleviate the symptoms of osteoarthritis, a degenerative joint disease characterized by the breakdown of cartilage and the underlying bone. These therapeutics include medications, physical therapies, lifestyle modifications, and in some cases, surgical procedures. The primary goals of osteoarthritis therapeutics are to reduce pain, improve joint function, and enhance the quality of life for individuals affected by the condition.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19634
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
